[go: up one dir, main page]

CN105837730B - Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction - Google Patents

Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction Download PDF

Info

Publication number
CN105837730B
CN105837730B CN201610183773.7A CN201610183773A CN105837730B CN 105837730 B CN105837730 B CN 105837730B CN 201610183773 A CN201610183773 A CN 201610183773A CN 105837730 B CN105837730 B CN 105837730B
Authority
CN
China
Prior art keywords
solution
ada
modified
multilayer film
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610183773.7A
Other languages
Chinese (zh)
Other versions
CN105837730A (en
Inventor
陈红
于谦
曹利敏
韦婷
渠阳翠
胡昌明
占文俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Hongfeng Hongfeng Biological Science And Technology Co Ltd
Original Assignee
Suzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou University filed Critical Suzhou University
Priority to CN201610183773.7A priority Critical patent/CN105837730B/en
Publication of CN105837730A publication Critical patent/CN105837730A/en
Application granted granted Critical
Publication of CN105837730B publication Critical patent/CN105837730B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04Acids; Metal salts or ammonium salts thereof
    • C08F220/06Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/08Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/38Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428Vitamins, e.g. tocopherol, riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明涉及生物医用工程以及高分子材料领域,提供了一种结合层层组装技术和主客体相互作用构建生物活性表面的方法。本发明通过简单的共聚合技术将客体分子金刚烷(Ada)基团引入到聚丙烯酸(PAA)上得到丙烯酸单体与丙烯酸金刚烷甲醇酯单体的共聚物(P(AA‑Ada));而后利用层层组装(LbL)技术在多种氨基化的基材表面沉积P(AA‑Ada)和聚丙烯胺(PAH)的聚电解质多层膜。利用聚电解质多层膜上所含有的大量金刚烷基团可以高密度地固定修饰了不同生物分子的β‑环糊精(β‑CD)衍生物,从而得到具有对应功能的生物活性表面。本发明的突出特点是:该方法具有普适性,可应用于多种不同化学性质、形状的基材;且构建的生物活性表面性能可调,适用于较广的生物医用领域。

The invention relates to the fields of biomedical engineering and polymer materials, and provides a method for constructing a bioactive surface in combination with layer-by-layer assembly technology and host-guest interaction. The present invention introduces the guest molecule adamantane (Ada) group into polyacrylic acid (PAA) through a simple copolymerization technique to obtain a copolymer of acrylic acid monomer and adamantyl methyl acrylate monomer (P(AA‑Ada)); Polyelectrolyte multilayer films of P(AA‑Ada) and polyallylamine (PAH) were then deposited on the surface of various aminated substrates using layer-by-layer (LbL) technology. A large number of adamantane groups contained in the polyelectrolyte multilayer film can be used to immobilize β-cyclodextrin (β-CD) derivatives modified with different biomolecules at high density, so as to obtain a bioactive surface with corresponding functions. The outstanding features of the present invention are: the method is universal and can be applied to substrates with different chemical properties and shapes; and the properties of the constructed bioactive surface can be adjusted, which is applicable to a wide range of biomedical fields.

Description

一种结合层层组装技术和主客体相互作用构建生物活性表面 的方法A combination of layer-by-layer assembly technology and host-guest interaction to construct bioactive surfaces Methods

技术领域technical field

本发明涉及生物医用功能高分子材料领域,具体涉及一种结合层层组装技术和主客体相互作用在多种基材上构建生物活性表面的制备方法。The invention relates to the field of biomedical functional polymer materials, in particular to a preparation method for constructing bioactive surfaces on various substrates in combination with layer-by-layer assembly technology and host-guest interaction.

背景技术Background technique

生物活性表面是指将蛋白质、多肽、核酸、多糖等生物功能分子通过物理或化学方法固定在合成材料表面,进而赋予表面特定的生物活性功能(比如生物分子识别性能,杀菌性能,抗凝血性能,抗污性能等),这在诸多生物医用工程和生物技术领域有着广泛应用。因此,如何简单、高效、普适地对生物材料进行表面改性以构建生物活性表面具有重要意义。通常生物活性表面的构建是首先在材料表面形成一层基质,而后将生物功能分子固定或负载在基质中。聚合物由于其生物相容性好,具有多个活性位点,功能性强,易于表面改性等优点被广泛采用作为基质。通常采用的聚合物基质制备方法主要包括自组装,Langmuir-Blodgett膜,聚合物涂层,表面引发聚合,层层组装技术等。这其中,层层组装技术是一种基于静电相互作用将带有不同电荷的聚合物交替层层吸附在基材表面的改性方法。与其他方法相比,层层组装技术具有操作简单、聚合物膜参数方便控制,几乎可以适用于任何形状和物理性质的基材等多种优点。特别地,层层组装技术形成的聚合物膜具有三维结构,非常适合负载固定生物活性分子,通过简单地改变多层膜的厚度,便可以有效地控制固定生物分子的数量。Bioactive surface refers to the immobilization of biological functional molecules such as proteins, polypeptides, nucleic acids, polysaccharides, etc. on the surface of synthetic materials by physical or chemical methods, and then endows the surface with specific bioactive functions (such as biomolecular recognition performance, bactericidal performance, anticoagulant performance) , anti-fouling properties, etc.), which have been widely used in many fields of biomedical engineering and biotechnology. Therefore, how to modify the surface of biological materials in a simple, efficient and universal way to construct bioactive surfaces is of great significance. Usually, the bioactive surface is constructed by first forming a layer of matrix on the surface of the material, and then immobilizing or loading biofunctional molecules in the matrix. Polymers are widely used as substrates due to their good biocompatibility, multiple active sites, strong functionality, and easy surface modification. The commonly used polymer matrix preparation methods mainly include self-assembly, Langmuir-Blodgett membrane, polymer coating, surface-initiated polymerization, layer-by-layer assembly technology, etc. Among them, the layer-by-layer assembly technology is a modification method that adsorbs alternate layers of polymers with different charges on the surface of the substrate based on electrostatic interactions. Compared with other methods, layer-by-layer assembly technology has many advantages such as simple operation, convenient control of polymer film parameters, and almost any substrate with any shape and physical properties. In particular, the polymer film formed by the layer-by-layer assembly technique has a three-dimensional structure, which is very suitable for loading and immobilizing bioactive molecules, and the number of immobilized biomolecules can be effectively controlled by simply changing the thickness of the multilayer film.

将生物分子固定在材料表面的常见方法是采用化学方法将生物分子通过共价键结合在基质上。虽然该方法结合力较强,但通常需要复杂的操作和采用有机溶剂等。近年来,采用基于弱相互作用的亲和固定受到广泛地关注。主客体相互作用是一种常见的超分子化学作用,事先将主体分子(或客体分子)进行生物分子后修饰,便可以通过主客体相互作用在温和的条件下简便地实现生物分子的固定。β-环糊精(β-CD)是一种常见的主体分子,其疏水性的空腔方便多种客体小分子的嵌入。β-CD本身具有多个方便活化的羟基,可以实现在一个分子上结合多个生物小分子配体,从而提高局部配体密度进而使得后修饰的β-CD具有更高的生物活性。此外,从化学角度出发,我们可以对β-CD进行后修饰得到具有不同功能的β-CD衍生物。应用主客体相互作用,可以通过简单地混合两种甚至多种生物分子后修饰的β-CD衍生物,实现赋予同一表面上双功能甚至多功能。A common method for immobilizing biomolecules on the surface of materials is to chemically bind the biomolecules to the substrate through covalent bonds. Although this method has a strong binding force, it usually requires complicated operations and the use of organic solvents. In recent years, the use of affinity immobilization based on weak interactions has received extensive attention. Host-guest interaction is a common supramolecular chemical interaction. After the host molecule (or guest molecule) is post-modified by biomolecules, the immobilization of biomolecules can be easily realized under mild conditions through host-guest interaction. β-cyclodextrin (β-CD) is a common host molecule, and its hydrophobic cavity facilitates the insertion of various guest small molecules. β-CD itself has multiple conveniently activated hydroxyl groups, which can realize the binding of multiple biological small molecule ligands on one molecule, thereby increasing the local ligand density and making the post-modified β-CD have higher biological activity. In addition, from a chemical point of view, we can post-modify β-CD to obtain β-CD derivatives with different functions. Applying host-guest interactions, it is possible to achieve bifunctional or even multifunctional endowment on the same surface by simply mixing two or even multiple biomolecular post-modified β-CD derivatives.

本发明选用层层组装常用的聚阴离子/聚阳离子对聚丙烯酸/聚丙烯胺(PAA/PAH)和典型的主客体对β-环糊精/金刚烷(β-CD/Ada)作为模型。首先通过简单的共聚合技术将Ada基团引入到聚阴离子PAA上得到共聚物P(AA-Ada),而后利用层层组装技术在多种基材表面沉积P(AA-Ada)/PAH多层膜,最后通过主客体相互作用将修饰有生物活性分子的β-CD引入到聚电解质多层膜中得到具有对应功能的生物活性表面。The present invention selects polyanion/polycation pair polyacrylic acid/polyacrylamine (PAA/PAH) commonly used in layer-by-layer assembly and typical host-guest pair β-cyclodextrin/adamantane (β-CD/Ada) as models. First, the Ada group was introduced into the polyanion PAA by a simple copolymerization technique to obtain the copolymer P(AA-Ada), and then the P(AA-Ada)/PAH multilayer was deposited on the surface of various substrates by using the layer-by-layer assembly technique Finally, the β-CD modified with bioactive molecules was introduced into the polyelectrolyte multilayer film through host-guest interaction to obtain a bioactive surface with corresponding functions.

发明内容Contents of the invention

本发明所要解决的技术问题是:针对目前生物活性表面制备方法所存在的反应过程复杂、基材有限、固定生物活性分子种类有限、功能单一的问题,提供一种操作简单、具有普适性的,可以固定多种生物活性分子,赋予表面多种生物功能的表面改性方法。The technical problem to be solved by the present invention is to provide a simple and universal bioactive surface preparation method for the problems of complex reaction process, limited substrate, limited types of immobilized bioactive molecules, and single function. , a surface modification method that can immobilize a variety of bioactive molecules and endow the surface with a variety of biological functions.

本发明解决其技术问题采用以下的技术方案:The present invention solves its technical problem and adopts the following technical solutions:

本发明提供的一种构建具有对应生物功能的材料的制备方法,其特征在于,包括以下步骤:A preparation method for constructing materials with corresponding biological functions provided by the present invention is characterized in that it comprises the following steps:

(1)聚电解质多层膜改性表面的制备:(1) Preparation of modified surface of polyelectrolyte multilayer film:

将氨基化的基材浸泡在丙烯酸单体与1-丙烯酸金刚烷甲醇酯单体的共聚物(P(AA-Ada))的溶液中一段时间,然后再浸泡在聚丙烯胺(PAH)溶液中一段时间,即在氨基化的基材表面得到一层P(AA-Ada)/PAH双分子层,重复浸泡若干次,即得到具有若干层P(AA-Ada)/PAH双分子层的聚电解质多层膜改性表面;The aminated substrate was soaked in a solution of a copolymer of acrylic acid monomer and adamantylmethanol 1-acrylate monomer (P(AA-Ada)) for a period of time and then in a solution of polyallylamine (PAH) For a period of time, one layer of P(AA-Ada)/PAH bimolecular layer is obtained on the surface of the aminated substrate, and the polyelectrolyte with several layers of P(AA-Ada)/PAH bimolecular layer is obtained after repeated soaking several times. Multilayer film modified surface;

(2)聚电解质多层膜改性表面固定生物活性分子:(2) Polyelectrolyte multilayer membrane modified surface immobilized bioactive molecules:

将所得的具有聚电解质多层膜改性表面置于含有修饰了生物活性分子的β-CD衍生物的溶液中进行反应,即得到固定有生物活性分子的聚电解质多层膜改性表面。The obtained polyelectrolyte multilayer modified surface is placed in a solution containing the β-CD derivative modified with bioactive molecules for reaction, and the polyelectrolyte multilayer modified surface with bioactive molecules immobilized is obtained.

本发明提供的另一种构建具有对应生物功能的材料的制备方法,其特征在于,包括以下步骤:Another preparation method for constructing materials with corresponding biological functions provided by the present invention is characterized in that it includes the following steps:

(1)含有金刚烷基团的聚阴离子P(AA-Ada)的制备:(1) Preparation of polyanion P(AA-Ada) containing adamantane groups:

按一定的摩尔比将丙烯酸单体、1-丙烯酸金刚烷甲醇酯单体、链转移剂和引发剂加入到反应溶液中进行聚合反应,反应后采用沉降分离提纯的方法即得含有金刚烷基团的聚阴离子P(AA-Ada);According to a certain molar ratio, acrylic acid monomer, 1-adamantyl acrylate monomer, chain transfer agent and initiator are added to the reaction solution for polymerization reaction. After the reaction, the method of sedimentation separation and purification is used to obtain the The polyanion P(AA-Ada);

(2)聚电解质多层膜改性表面的制备:(2) Preparation of modified surface of polyelectrolyte multilayer film:

将氨基化的基材浸泡在丙烯酸单体与1-丙烯酸金刚烷甲醇酯单体的共聚物(P(AA-Ada))的溶液中一段时间,然后再浸泡在聚丙烯胺(PAH)溶液中一段时间,即在氨基化的基材表面得到一层P(AA-Ada)/PAH双分子层,重复浸泡若干次,即得到具有若干层P(AA-Ada)/PAH双分子层的聚电解质多层膜改性表面;The aminated substrate was soaked in a solution of a copolymer of acrylic acid monomer and adamantylmethanol 1-acrylate monomer (P(AA-Ada)) for a period of time and then in a solution of polyallylamine (PAH) For a period of time, one layer of P(AA-Ada)/PAH bimolecular layer is obtained on the surface of the aminated substrate, and the polyelectrolyte with several layers of P(AA-Ada)/PAH bimolecular layer is obtained after repeated soaking several times. Multilayer film modified surface;

(3)聚电解质多层膜改性表面固定生物活性分子:(3) Polyelectrolyte multilayer film modified surface to immobilize bioactive molecules:

将所得的具有聚电解质多层膜改性表面置于含有修饰了生物活性分子的β-CD衍生物的溶液中进行反应,即得到固定有生物活性分子的聚电解质多层膜改性表面。The obtained polyelectrolyte multilayer modified surface is placed in a solution containing the β-CD derivative modified with bioactive molecules for reaction, and the polyelectrolyte multilayer modified surface with bioactive molecules immobilized is obtained.

进一步,所述的生物活性分子为生物素、甘露糖或精氨酸-谷氨酸-天冬氨酸-缬氨酸多肽。Further, the bioactive molecule is biotin, mannose or arginine-glutamic acid-aspartic acid-valine polypeptide.

进一步,修饰有所述生物素分子的β-CD衍生物的制备过程为:将炔丙基生物素和7个叠氮基团修饰的β-CD(β-CD-(N3)7)进行点击反应,制得生物素修饰的β-CD。Further, the preparation process of the β-CD derivative modified with the biotin molecule is as follows: the β-CD (β-CD-(N 3 ) 7 ) modified by propargyl biotin and 7 azido groups Click reaction to prepare biotin-modified β-CD.

进一步,修饰有所述甘露糖分子的β-CD衍生物的制备过程为:将炔丙基甘露糖和7个叠氮基团修饰的β-CD(β-CD-(N3)7)进行点击反应,制得甘露糖修饰的β-CD。Further, the preparation process of the β-CD derivative modified with the mannose molecule is as follows: β-CD (β-CD-(N 3 ) 7 ) modified with propargyl mannose and 7 azide groups Click reaction to prepare mannose-modified β-CD.

进一步,修饰有所述精氨酸-谷氨酸-天冬氨酸-缬氨酸多肽分子的β-CD衍生物的制备过程为:将炔丙基-精氨酸-谷氨酸-天冬氨酸-缬氨酸多肽和7个叠氮基团修饰的β-CD(β-CD-(N3)7)进行点击反应,制得精氨酸-谷氨酸-天冬氨酸-缬氨酸多肽修饰的β-CD。Further, the preparation process of the β-CD derivative modified with the arginine-glutamic acid-aspartic acid-valine polypeptide molecule is as follows: propargyl-arginine-glutamic acid-aspartate Arginine-Glutamate-Valine Polypeptide and β-CD Modified with 7 Azide Groups (β-CD-(N 3 ) 7 ) Click Reaction to Prepare Arginine-Glutamate-Aspartate-Valine Amino acid peptide modified β-CD.

进一步,所述氨基化的基材为单晶硅或玻璃,所述氨基化的单晶硅片或玻璃片的制备过程为:将单晶硅片或玻璃片置于3-氨基丙基-三乙氧基硅烷(APTES)的甲苯溶液中反应一段时间,得到表面氨基化的单晶硅或玻璃基材。Further, the aminated base material is single crystal silicon or glass, and the preparation process of the aminated single crystal silicon sheet or glass sheet is as follows: the single crystal silicon sheet or glass sheet is placed in 3-aminopropyl-three Ethoxysilane (APTES) in toluene solution to react for a period of time to obtain surface aminated single crystal silicon or glass substrate.

进一步,所述氨基化的基材为镀金单晶硅片,所述氨基化的镀金单晶硅片的制备过程为:将镀金单晶硅片置于巯基乙胺盐酸盐的水溶液中反应一段时间,得到表面氨基化的镀金单晶硅基材。Further, the aminated substrate is a gold-plated single crystal silicon wafer, and the preparation process of the aminated gold-plated single crystal silicon wafer is as follows: placing the gold-plated single crystal silicon wafer in an aqueous solution of mercaptoethylamine hydrochloride for a period of reaction time, a gold-plated single crystal silicon substrate with surface amination was obtained.

进一步,修饰了生物活性分子的β-CD衍生物的溶液为水溶液、磷酸盐缓冲溶液或其他可以溶解相应生物活性分子的溶液。Further, the solution of the β-CD derivative modified with the bioactive molecule is an aqueous solution, a phosphate buffer solution or other solutions that can dissolve the corresponding bioactive molecule.

进一步,所述的聚合为可逆加成断裂链转移聚合,所述链转移剂为2-(苯基硫代甲酰硫基)丙酸;所述的引发剂为偶氮二异丁腈、偶氮二异庚腈、过氧化二苯甲酰、过氧化二碳酸二乙基己酯、异丙苯过氧化氢、过硫酸钾—亚硫酸盐体系或过氧化氢—亚铁酸盐体系。Further, the polymerization is reversible addition-fragmentation chain transfer polymerization, and the chain transfer agent is 2-(phenylthioformylthio)propionic acid; the initiator is azobisisobutyronitrile, azo Diisoheptanonitrile, dibenzoyl peroxide, diethylhexyl peroxydicarbonate, cumene hydroperoxide, potassium persulfate-sulfite system or hydrogen peroxide-ferrite system.

进一步,所述含链转移剂的溶液为N,N-二甲基甲酰胺溶液,所述含引发剂的溶液为N,N-二甲基甲酰胺溶液。Further, the solution containing the chain transfer agent is N,N-dimethylformamide solution, and the solution containing the initiator is N,N-dimethylformamide solution.

进一步,7个叠氮基团修饰的β-CD(β-CD-(N3)7)的制备方法为:先将β-CD六号位的羟基进行溴取代(β-CD-(Br)7)或碘取代(β-CD-(I)7),然后用叠氮化钠进行叠氮化。Further, the preparation method of β-CD modified with 7 azide groups (β-CD-(N 3 ) 7 ) is as follows: firstly, the hydroxyl group at the sixth position of β-CD is substituted with bromine (β-CD-(Br) 7 ) or iodine substitution (β-CD-(I) 7 ), followed by azidation with sodium azide.

本发明提供的一种构建具有对应生物功能的材料的制备方法,其包括以下详细具体步骤:The present invention provides a preparation method for constructing materials with corresponding biological functions, which includes the following detailed steps:

(1)含有金刚烷基团的聚阴离子P(AA-Ada)的制备:(1) Preparation of polyanion P(AA-Ada) containing adamantane groups:

在反应装置中,按一定的摩尔比将丙烯酸单体、1-丙烯酸金刚烷甲醇酯单体、链转移剂和引发剂加入反应溶液中,在氮气保护下搅拌反应,反应温度为65℃,反应时间为24小时;反应结束后用乙醚沉降,分离提纯后即可得到含有金刚烷基团的聚阴离子P(AA-Ada);所述P(AA-Ada) 为1-丙烯酸金刚烷甲醇酯单体与丙烯酸单体的共聚物的英文缩写;In the reaction device, acrylic acid monomer, 1-adamantyl acrylate monomer, chain transfer agent and initiator are added to the reaction solution according to a certain molar ratio, and the reaction is stirred under the protection of nitrogen. The reaction temperature is 65°C. The time is 24 hours; after the reaction is completed, it is settled with ether, and after separation and purification, the polyanion P(AA-Ada) containing adamantyl group can be obtained; the P(AA-Ada) is 1-adamantyl methyl acrylate The English abbreviation for the copolymer of monomer and acrylic acid monomer;

所述链转移剂为2-(苯基硫代甲酰硫基)丙酸;所述的引发剂为偶氮二异丁腈等;所述的反应溶液为DMF溶液。The chain transfer agent is 2-(phenylthioformylthio)propionic acid; the initiator is azobisisobutyronitrile, etc.; the reaction solution is DMF solution.

(2)聚电解质多层膜改性表面的制备:(2) Preparation of modified surface of polyelectrolyte multilayer film:

配制聚电解质溶液,包括聚阴离子P(AA-Ada)溶液和聚阳离子PAH溶液;将氨基化的基材浸泡在P(AA-Ada)溶液中,经过清洗去除结合较弱的聚合物后再浸泡在PAH溶液中,经过清洗后即可在表面得到一个P(AA-Ada)/PAH的双分子层,此过程重复若干次最后达到需要的层数,得到聚电解质多层膜改性表面;Prepare polyelectrolyte solutions, including polyanion P(AA-Ada) solution and polycation PAH solution; soak the aminated substrate in P(AA-Ada) solution, wash to remove weakly bound polymers, and then soak In the PAH solution, after cleaning, a P(AA-Ada)/PAH bimolecular layer can be obtained on the surface. This process is repeated several times to finally reach the required number of layers, and the modified surface of the polyelectrolyte multilayer film is obtained;

所述的聚电解质溶液为pH值为5.0的醋酸/醋酸钠缓冲溶液;从聚电解质溶液中取出的表面的清洗溶液为pH值为5.0的醋酸/醋酸钠缓冲溶液;所述氨基化的基材为单晶硅、玻璃或镀金单晶硅。The polyelectrolyte solution is an acetic acid/sodium acetate buffer solution with a pH value of 5.0; the surface cleaning solution taken out from the polyelectrolyte solution is an acetic acid/sodium acetate buffer solution with a pH value of 5.0; the aminated substrate Monocrystalline silicon, glass or gold-plated monocrystalline silicon.

所述氨基化的基材的制备过程包括以下步骤:The preparation process of the base material of described amination comprises the following steps:

(a)将洗净的单晶硅片或玻璃片先用“piranha”溶液(硫酸:双氧水=7:3, 体积比)进行预处理,然后置于3-氨基丙基-三乙氧基硅烷(APTES)的甲苯溶液中反应过夜,得到表面氨基化的单晶硅或玻璃基材;(a) Pre-treat the cleaned single crystal silicon wafer or glass wafer with "piranha" solution (sulfuric acid:hydrogen peroxide=7:3, volume ratio), and then place it in 3-aminopropyl-triethoxysilane (APTES) in toluene solution to react overnight to obtain surface aminated single crystal silicon or glass substrate;

(b)将经过紫外臭氧仪洗净的镀金单晶硅片用氨水,双氧水和去离子水的混合溶液(氨水:双氧水:去离子水 = 1:1:5, 体积比)进行预处理,然后置于巯基乙胺盐酸盐的水溶液中反应过夜,得到表面氨基化的镀金单晶硅基材;(b) Pretreat the gold-plated monocrystalline silicon wafers cleaned by the UV-ozone meter with a mixed solution of ammonia, hydrogen peroxide and deionized water (ammonia: hydrogen peroxide: deionized water = 1:1:5, volume ratio), and then Placed in an aqueous solution of mercaptoethylamine hydrochloride to react overnight to obtain a gold-plated single crystal silicon substrate with an aminated surface;

(3)聚电解质多层膜改性表面固定生物活性分子:(3) Polyelectrolyte multilayer film modified surface to immobilize bioactive molecules:

将所得的聚电解质多层膜改性表面置于含有修饰了生物分子的β-CD衍生物的溶液中进行反应,反应温度为室温,反应时间为12~24小时,反应结束后用去离子水清洗表面,即可得到固定有生物活性分子的聚电解质多层膜改性表面;Put the modified surface of the obtained polyelectrolyte multilayer film in a solution containing β-CD derivatives modified with biomolecules for reaction, the reaction temperature is room temperature, and the reaction time is 12 to 24 hours. After cleaning the surface, the modified surface of polyelectrolyte multilayer film immobilized with bioactive molecules can be obtained;

所述的生物活性分子为生物素、甘露糖和REDV多肽;所述的修饰了生物活性分子的β-CD衍生物的溶液为水溶液、磷酸盐缓冲溶液或其他可以溶解相应生物活性分子的溶液。The biologically active molecules are biotin, mannose and REDV polypeptide; the solution of the β-CD derivative modified with the biologically active molecules is aqueous solution, phosphate buffer solution or other solutions that can dissolve the corresponding biologically active molecules.

所述修饰有生物活性分子的β-CD衍生物的制备过程包括以下步骤:The preparation process of the β-CD derivative modified with biologically active molecules comprises the following steps:

(a)7个叠氮基团修饰的β-CD(β-CD-(N3)7)的制备;(a) Preparation of β-CD modified with 7 azide groups (β-CD-(N 3 ) 7 );

(b)生物素修饰的β-CD的制备:(b) Preparation of biotin-modified β-CD:

在反应装置中,先加入β-CD-(N3)7和biotin-PEG4-alkyne,而后在氮气保护下加入催化剂/配体溶液,搅拌反应,反应温度为50℃,反应时间为36小时,反应结束后将混合溶液用MWCO 1000的透析袋透析,冷冻干燥后即可得到生物素修饰的β-CD。In the reaction device, first add β-CD-(N 3 ) 7 and biotin-PEG 4 -alkyne, then add the catalyst/ligand solution under the protection of nitrogen, stir the reaction, the reaction temperature is 50°C, and the reaction time is 36 hours After the reaction, the mixed solution was dialyzed with a dialysis bag of MWCO 1000, and the biotin-modified β-CD could be obtained after freeze-drying.

(c)甘露糖修饰的β-CD的制备:(c) Preparation of mannose-modified β-CD:

氮气保护下将1-(2’-炔丙基)-α-D-甘露糖和β-CD-(N3)7加入催化剂体系溶液中,进行点击反应,反应温度为为50℃,反应时间为24小时,反应结束后除去溶剂,用无水甲醇离心收集沉淀,提纯后即可得到甘露糖修饰的β-CD。Under the protection of nitrogen, add 1-(2'-propargyl)-α-D-mannose and β-CD-(N 3 ) 7 into the catalyst system solution for click reaction, the reaction temperature is 50°C, and the reaction time is After 24 hours, the solvent was removed after the reaction, and the precipitate was collected by centrifugation with anhydrous methanol, and the mannose-modified β-CD could be obtained after purification.

(d)REDV多肽修饰的β-CD的制备:(d) Preparation of β-CD modified by REDV polypeptide:

氮气保护下将炔丙基-REDV和β-CD-(N3)7加入催化剂体系溶液中,进行点击反应,反应温度为为50℃,反应时间为24小时,反应后处理为使用MWCO 500的透析袋透析,冷冻干燥即可获得REDV多肽修饰的β-CD。Under the protection of nitrogen, add propargyl-REDV and β-CD-(N 3 ) 7 into the catalyst system solution for click reaction, the reaction temperature is 50°C, the reaction time is 24 hours, and the post-reaction treatment is to use MWCO 500 The β-CD modified by REDV polypeptide can be obtained by dialyzing the dialysis bag and freeze-drying.

优选的,步骤(a)中所述的制备方法为以下一种或者两种:Preferably, the preparation method described in step (a) is one or both of the following:

先将β-CD六号位的羟基进行溴取代(β-CD-(Br)7),然后用叠氮化钠进行叠氮化;Firstly, the hydroxyl group at the sixth position of β-CD is replaced by bromine (β-CD-(Br) 7 ), and then azidated with sodium azide;

先将β-CD六号位的羟基进行碘取代(β-CD-(I)7),然后用叠氮化钠进行叠氮化。The hydroxyl group at the sixth position of β-CD is replaced with iodine (β-CD-(I) 7 ), and then azide is carried out with sodium azide.

优选的,步骤(b)中所述的催化剂/配体溶液为二甲基亚砜溶液,所述催化剂/配体体系为2,2'-联吡啶/溴化铜等。Preferably, the catalyst/ligand solution described in step (b) is a dimethyl sulfoxide solution, and the catalyst/ligand system is 2,2'-bipyridyl/copper bromide and the like.

优选的,步骤(c)中所述的催化剂溶液为二甲基亚砜溶液,所述催化剂/配体体系为2,2'-联吡啶/溴化铜等。Preferably, the catalyst solution described in step (c) is a dimethyl sulfoxide solution, and the catalyst/ligand system is 2,2'-bipyridine/copper bromide and the like.

优选的,步骤(d)中所述的催化剂体系溶液为二甲基亚砜/水混合溶液,所述催化体系为硫酸铜/抗坏血酸钠等。Preferably, the catalyst system solution described in step (d) is a mixed solution of dimethyl sulfoxide/water, and the catalyst system is copper sulfate/sodium ascorbate and the like.

经过上述步骤,最终得到具有对应生物功能的高密度固定生物功能分子的生物活性表面。After the above steps, a bioactive surface with high-density immobilized biofunctional molecules with corresponding biological functions is finally obtained.

本发明与现有技术相比具有以下主要的优点:Compared with the prior art, the present invention has the following main advantages:

本发明提供的方法为结合层层组装技术和主客体相互作用制备生物活性表面的方法。与现有技术相比,本发明具有以下突出特点:The method provided by the invention is a method for preparing a bioactive surface by combining layer-by-layer assembly technology and host-guest interaction. Compared with the prior art, the present invention has the following prominent features:

1. 操作简单、易行:层层组装及主客体反应条件温和,能够在室温,水溶液环境下完成。1. Simple and easy to operate: layer-by-layer assembly and host-guest reaction conditions are mild, and can be completed at room temperature and in an aqueous solution environment.

2. 适用性较广:层层组装技术构建聚电解质多层膜的方法可以应用于不同化学性质,不同形状的基材,可以在任何含有氨基的基材表面实现,适用于如生物检测、组织工程、蛋白质分离纯化等许多生物医用领域。2. Wide applicability: The method of constructing polyelectrolyte multilayer films by layer-by-layer assembly technology can be applied to substrates of different chemical properties and shapes, and can be realized on the surface of any substrate containing amino groups. It is suitable for biological detection, tissue Engineering, protein separation and purification and many other biomedical fields.

3. 表面性能可调:一方面可以简单地通过改变层层组装层数控制负载生物分子的容量,另一方面可以根据需要设计不同生物功能分子修饰的β-CD赋予表面不同的生物功能。例如,在利用本方法得到的聚电解质多层膜表面固定生物素修饰的β-CD后,可以选择性结合亲和素(见图1);在表面固定甘露糖修饰的β-CD后,可以特异性的吸附刀豆蛋白(ConA)(见图2);在表面固定REDV多肽修饰的β-CD后,可以促进表面内皮细胞的黏附(见图3)。3. Adjustable surface properties: On the one hand, the capacity of loaded biomolecules can be controlled simply by changing the number of layers assembled, and on the other hand, β-CD modified with different biofunctional molecules can be designed to endow the surface with different biological functions. For example, after immobilizing biotin-modified β-CD on the surface of the polyelectrolyte multilayer film obtained by this method, avidin can be selectively bound (see Figure 1); after immobilizing mannose-modified β-CD on the surface, it can Specific adsorption of concanavalin (ConA) (see Figure 2); after immobilizing REDV polypeptide-modified β-CD on the surface, it can promote the adhesion of surface endothelial cells (see Figure 3).

附图说明Description of drawings

图1为单晶硅片聚电解质多层膜表面固定生物素修饰的β-CD前后表面对荧光修饰的亲和素的吸附情况;Figure 1 shows the adsorption of fluorescence-modified avidin on the surface of a polyelectrolyte multilayer film on a single crystal silicon wafer before and after immobilization of biotin-modified β-CD;

图2为镀金单晶硅片聚电解质多层膜表面固定甘露糖修饰的β-CD前后表面对荧光修饰的刀豆蛋白的吸附情况。Figure 2 shows the adsorption of fluorescence-modified concanavalin on the surface of the gold-plated single-crystal silicon wafer polyelectrolyte multilayer film before and after immobilization of mannose-modified β-CD.

图3为镀金单晶硅片基材上聚电解质多层膜表面固定REDV多肽修饰的β-CD前后表面对内皮细胞的黏附情况。Figure 3 shows the adhesion to endothelial cells before and after the REDV polypeptide-modified β-CD is immobilized on the surface of the polyelectrolyte multilayer film on the gold-plated single crystal silicon substrate.

具体实施方式detailed description

本发明提供的结合层层组装技术和主客体相互作用构建生物活性表面的方法,是先对基材表面进行氨基化预处理,再将聚电解质P(AA-Ada)与PAH通过层层组装技术在表面沉积得到含有Ada基团的聚电解质多层膜。最后利用Ada与β-CD之间的主客体相互作用,于聚电解质多层膜表面固定修饰有不同生物活性分子的β-CD,赋予表面对应的生物功能。The method provided by the present invention for constructing a biologically active surface in combination with layer-by-layer assembly technology and host-guest interaction is to firstly carry out amination pretreatment on the surface of the substrate, and then use polyelectrolyte P (AA-Ada) and PAH through layer-by-layer assembly technology A polyelectrolyte multilayer film containing Ada groups was deposited on the surface. Finally, by using the host-guest interaction between Ada and β-CD, β-CD modified with different bioactive molecules was immobilized on the surface of the polyelectrolyte multilayer membrane, endowing the surface with corresponding biological functions.

下面通过实施例,对本发明作进一步阐述,但并不限定本发明。Below by embodiment, the present invention is described further, but does not limit the present invention.

实施例1Example 1

结合层层组装技术与主客体相互作用于单晶硅片表面构建具有生物分子识别功能的表面Combining layer-by-layer assembly technology and host-guest interaction to construct a surface with biomolecular recognition function on the surface of a single crystal silicon wafer

将用丙酮溶液超声洗净的单晶硅片用“piranha”溶液(硫酸:双氧水=7:3, 体积比)进行预处理,然后置于3-氨基丙基-三乙氧基硅烷(APTES)的甲苯溶液中反应18小时,即得到表面氨基化的单晶硅片。分别配制聚阴离子P(AA-Ada)溶液和聚阳离子PAH溶液,溶剂为pH值为5.0的浓度为0.05 摩尔/升的醋酸/醋酸钠缓冲溶液。将氨基化的单晶硅片浸泡在P(AA-Ada)溶液中,经过醋酸/醋酸钠缓冲溶液清洗去除结合较弱的聚合物后再浸泡在PAH溶液中,经过清洗后在表面得到一个P(AA-Ada)/PAH的双分子层,此过程重复若干次最后达到需要的层数,即可得到聚电解质多层膜改性的单晶硅片。The monocrystalline silicon wafers cleaned ultrasonically with acetone solution were pretreated with "piranha" solution (sulfuric acid:hydrogen peroxide=7:3, volume ratio), and then placed in 3-aminopropyl-triethoxysilane (APTES) react in a toluene solution for 18 hours to obtain a monocrystalline silicon wafer with surface amination. A polyanion P(AA-Ada) solution and a polycation PAH solution were respectively prepared, and the solvent was an acetic acid/sodium acetate buffer solution with a pH value of 5.0 and a concentration of 0.05 mol/L. Soak the aminated monocrystalline silicon wafer in the P(AA-Ada) solution, wash it with acetic acid/sodium acetate buffer solution to remove the weakly bonded polymer, and then soak it in the PAH solution. After cleaning, a P (AA-Ada)/PAH bimolecular layer, this process is repeated several times until the required number of layers is reached, and a polyelectrolyte multilayer film modified single crystal silicon wafer can be obtained.

先将β-CD六号位的羟基进行溴取代(β-CD-(Br)7),然后用叠氮化钠进行叠氮化制备7个叠氮基团修饰的β-CD(β-CD-(N3)7);最后将β-CD-(N3)7和炔丙基生物素进行点击反应,得到生物素修饰的β-CD(β-CD-(biotin)7)。Firstly, the hydroxyl group at the sixth position of β-CD is replaced by bromine (β-CD-(Br) 7 ), and then azide is used to prepare β-CD modified with 7 azido groups (β-CD -(N 3 ) 7 ); Finally, click reaction was performed on β-CD-(N 3 ) 7 and propargyl biotin to obtain biotin-modified β-CD (β-CD-(biotin) 7 ).

将上述聚电解质多层膜改性的单晶硅片置于1毫摩尔每升的β-CD-(biotin)7水溶液中,并在室温下反应过夜。反应结束后用水清洗表面,即可得到固定了生物素的具有生物分子识别功能的表面。The above polyelectrolyte multilayer modified single crystal silicon wafer was placed in 1 millimole per liter of β-CD-(biotin) 7 aqueous solution, and reacted overnight at room temperature. After the reaction, the surface is washed with water to obtain a biotin-immobilized surface with a biomolecular recognition function.

实施例2Example 2

结合层层组装技术与主客体相互作用于镀金单晶硅片表面构建具有特异性吸附刀豆蛋白功能的表面Combining layer-by-layer assembly technology and host-guest interaction to construct a surface with specific adsorption function of concanavalin on the surface of gold-plated single crystal silicon wafer

将用经过紫外臭氧仪洗净的镀金单晶硅片用氨水,双氧水和去离子水的混合溶液(氨水:双氧水:去离子水 = 1:1:5, 体积比)进行预处理,然后置于巯基乙胺盐酸盐的水溶液中反应过夜,即得到表面氨基化的镀金单晶硅片。分别配制聚阴离子P(AA-Ada)溶液和聚阳离子PAH溶液,溶剂为pH值为5.0的浓度为0.05 摩尔/升的醋酸/醋酸钠缓冲溶液。将氨基化的镀金单晶硅片浸泡在P(AA-Ada)溶液中,经过醋酸/醋酸钠缓冲溶液清洗去除结合较弱的聚合物后再浸泡在PAH溶液中,经过清洗后在表面得到一个P(AA-Ada)/PAH的双分子层,此过程重复若干次最后达到需要的层数,即可得到聚电解质多层膜改性的镀金单晶硅片。The gold-plated monocrystalline silicon wafers cleaned by the UV-ozone meter were pretreated with a mixed solution of ammonia, hydrogen peroxide and deionized water (ammonia: hydrogen peroxide: deionized water = 1:1:5, volume ratio), and then placed in React overnight in an aqueous solution of mercaptoethylamine hydrochloride to obtain a gold-plated single-crystal silicon chip whose surface is aminated. A polyanion P(AA-Ada) solution and a polycation PAH solution were respectively prepared, and the solvent was an acetic acid/sodium acetate buffer solution with a pH value of 5.0 and a concentration of 0.05 mol/L. Soak the aminated gold-plated single crystal silicon wafer in the P(AA-Ada) solution, wash it with acetic acid/sodium acetate buffer solution to remove the weakly bonded polymer, and then soak it in the PAH solution. After cleaning, a A bimolecular layer of P(AA-Ada)/PAH, this process is repeated several times to finally reach the required number of layers, and a gold-plated single crystal silicon wafer modified by a polyelectrolyte multilayer film can be obtained.

先将β-CD六号位的羟基进行溴取代(β-CD-(Br)7),然后用叠氮化钠进行叠氮化制备7个叠氮基团修饰的β-CD(β-CD-(N3)7);最后将β-CD-(N3)7和1-(2’-炔丙基)-α-D-甘露糖进行点击反应,得到甘露糖修饰的β-CD(β-CD-(mannose)7)。Firstly, the hydroxyl group at the sixth position of β-CD is replaced by bromine (β-CD-(Br) 7 ), and then azide is used to prepare β-CD modified with 7 azido groups (β-CD -(N 3 ) 7 ); Finally, click reaction was performed on β-CD-(N 3 ) 7 and 1-(2'-propargyl)-α-D-mannose to obtain mannose-modified β-CD ( β-CD-(mannose) 7 ).

将上述聚电解质多层膜改性的镀金单晶硅片置于1毫摩尔每升的β-CD-(mannose)7水溶液中,并在室温下反应过夜。反应结束后用水清洗表面,即可得到固定了甘露糖的具有特异性吸附刀豆蛋白(Con A)功能的表面。The above-mentioned gold-plated single-crystal silicon wafer modified by the polyelectrolyte multilayer film was placed in 1 millimole per liter of β-CD-(mannose) 7 aqueous solution, and reacted overnight at room temperature. After the reaction, the surface is washed with water to obtain a surface with the function of specifically adsorbing concanavalin (Con A) immobilized with mannose.

实施例3Example 3

结合层层组装技术与主客体相互作用于镀金单晶硅片表面构建具有促进内皮细胞黏附功能的表面Combining layer-by-layer assembly technology and host-guest interaction to construct a surface with the function of promoting endothelial cell adhesion on the surface of gold-plated single crystal silicon wafer

将用经过紫外臭氧仪洗净的镀金单晶硅片用氨水,双氧水和去离子水的混合溶液(氨水:双氧水:去离子水 = 1:1:5,体积比)进行预处理,然后置于巯基乙胺盐酸盐的水溶液中反应过夜,即得到表面氨基化的镀金单晶硅片。分别配制聚阴离子P(AA-Ada)溶液和聚阳离子PAH溶液,溶剂为pH值为5.0的浓度为0.05 摩尔/升的醋酸/醋酸钠缓冲溶液。将氨基化的镀金单晶硅片浸泡在P(AA-Ada)溶液中,经过醋酸/醋酸钠缓冲溶液清洗去除结合较弱的聚合物后再浸泡在PAH溶液中,经过清洗后在表面得到一个P(AA-Ada)/PAH的双分子层,此过程重复若干次最后达到需要的层数,即可得到聚电解质多层膜改性的镀金单晶硅片。The gold-plated monocrystalline silicon wafers cleaned by the ultraviolet ozone instrument are pretreated with a mixed solution of ammonia, hydrogen peroxide and deionized water (ammonia: hydrogen peroxide: deionized water = 1:1:5, volume ratio), and then placed in React overnight in an aqueous solution of mercaptoethylamine hydrochloride to obtain a gold-plated single-crystal silicon chip whose surface is aminated. A polyanion P(AA-Ada) solution and a polycation PAH solution were respectively prepared, and the solvent was an acetic acid/sodium acetate buffer solution with a pH value of 5.0 and a concentration of 0.05 mol/L. Soak the aminated gold-plated single crystal silicon wafer in the P(AA-Ada) solution, wash it with acetic acid/sodium acetate buffer solution to remove the weakly bonded polymer, and then soak it in the PAH solution. After cleaning, a A bimolecular layer of P(AA-Ada)/PAH, this process is repeated several times to finally reach the required number of layers, and a gold-plated single crystal silicon wafer modified by a polyelectrolyte multilayer film can be obtained.

先将β-CD六号位的羟基进行溴取代(β-CD-(Br)7),然后用叠氮化钠进行叠氮化制备7个叠氮基团修饰的β-CD(β-CD-(N3)7);最后将β-CD-(N3)7和炔丙基-REDV多肽进行点击反应,得到REDV多肽修饰的β-CD(β-CD-(REDV)7)。Firstly, the hydroxyl group at the sixth position of β-CD is replaced by bromine (β-CD-(Br) 7 ), and then azide is used to prepare β-CD modified with 7 azido groups (β-CD -(N 3 ) 7 ); Finally, click reaction was performed on β-CD-(N 3 ) 7 and propargyl-REDV polypeptide to obtain β-CD modified by REDV polypeptide (β-CD-(REDV) 7 ).

将上述聚电解质多层膜改性的镀金单晶硅片置于1毫摩尔每升的β-CD-(REDV)7水溶液中,并在室温下反应过夜。反应结束后用水清洗表面,即可得到固定了REDV多肽的具有促进内皮细胞黏附功能的表面。The above-mentioned gold-plated single crystal silicon wafer modified by polyelectrolyte multilayer film was placed in 1 millimole per liter of β-CD-(REDV) 7 aqueous solution, and reacted overnight at room temperature. After the reaction, the surface is washed with water to obtain a surface with the function of promoting endothelial cell adhesion immobilized with the REDV polypeptide.

本方法在诸多生物医用和生物科技领域具有潜在的应用前景。其中需要特别指出的是该方法学不仅局限于我们工作采用的PAA/PAH,β-CD/Ada,而且可以推广到其他聚合物和其他主客体对。对于需要双功能甚至多功能表面的领域,可以简单地采用混合共引入的方式引入两种或多种具有不同配体的环糊精分子得以实现。The method has potential application prospects in many fields of biomedicine and biotechnology. It should be pointed out that the methodology is not limited to PAA/PAH and β-CD/Ada used in our work, but can be extended to other polymers and other host-guest pairs. For fields that require bifunctional or even multifunctional surfaces, it can be achieved simply by introducing two or more cyclodextrin molecules with different ligands by hybrid co-introduction.

以上依据本发明的理想实施例为启示,通过上述的说明内容,相关人员完全可以在不偏离本项发明技术思想的范围内,进行多样的变更以及修改。本项发明的技术性范围并不局限于说明书上的内容,必须要根据权利要求范围来确定技术性范围。The above is inspired by the ideal embodiment of the present invention. Through the above description, relevant personnel can make various changes and modifications within the scope of not departing from the technical idea of the present invention. The technical scope of the present invention is not limited to the content in the specification, and must be determined according to the scope of the claims.

Claims (10)

1. a kind of method that combination laminated assembling technology and host-guest interaction build bioactivity surface, it is characterised in that Comprise the following steps:
(1)The preparation of polyelectrolyte multilayer film modified surface:
Amidized base material is immersed in the copolymer p (AA-Ada) of acrylic monomers and 1- acrylic acid adamantane methanol ester monomers Solution in a period of time, a period of time is then immersed in polypropylene amine PAH solution again, i.e., is obtained in amidized substrate surface To one layer of P (AA-Ada)/PAH bilayer, immersion is repeated several times, if being had double points of dried layer P (AA-Ada)/PAH The polyelectrolyte multilayer film modified surface of sublayer;
(2)Polyelectrolyte multilayer film modified surface immobilizing biologically active molecule:
Gained is placed in polyelectrolyte multilayer film modified surface and spread out containing the beta-schardinger dextrin for having modified bioactive molecule Reacted in biological solution, that is, obtain being fixed with the polyelectrolyte multilayer film modified surface of bioactive molecule.
2. a kind of method that combination laminated assembling technology and host-guest interaction build bioactivity surface, it is characterised in that Comprise the following steps:
(1)The preparation of polyanion P (AA-Ada) containing adamantane group:
Acrylic monomers, 1- acrylic acid adamantane methanol ester monomer, chain-transferring agent and initiator are added by certain mol ratio Polymerisation is carried out into reaction solution, the method purified after reaction using sedimentation separation produces poly- the moon containing adamantane group Ion P (AA-Ada);
(2)The preparation of polyelectrolyte multilayer film modified surface:
Amidized base material is immersed in the copolymer p (AA-Ada) of acrylic monomers and 1- acrylic acid adamantane methanol ester monomers Solution in a period of time, a period of time is then immersed in polypropylene amine PAH solution again, i.e., is obtained in amidized substrate surface To one layer of P (AA-Ada)/PAH bilayer, immersion is repeated several times, if being had double points of dried layer P (AA-Ada)/PAH The polyelectrolyte multilayer film modified surface of sublayer;
(3)Polyelectrolyte multilayer film modified surface immobilizing biologically active molecule:
Gained is placed in polyelectrolyte multilayer film modified surface and spread out containing the beta-schardinger dextrin for having modified bioactive molecule Reacted in biological solution, that is, obtain being fixed with the polyelectrolyte multilayer film modified surface of bioactive molecule.
3. method according to claim 1 or 2, it is characterised in that:Described bioactive molecule is biotin, mannose Or arginine-glutamic acid-aspartic acid-valine polypeptide.
4. method according to claim 3, it is characterised in that:It is modified with the system of the β-cdderivatives of the biotin molecule It is for process:β-CD by propargyl biotin and the modification of 7 azido groups are:β-CD-(N3)7, click-reaction is carried out, is made β-the CD of biotin modification.
5. method according to claim 3, it is characterised in that:It is modified with the system of the β-cdderivatives of the mannose molecules It is for process:β-CD by propargyl mannose and the modification of 7 azido groups are:β-CD-(N3)7, click-reaction is carried out, is made β-the CD of mannose-modified.
6. method according to claim 3, it is characterised in that:It is modified with the arginine-glutamic acid-aspartic acid-figured silk fabrics The preparation process of the β-cdderivatives of propylhomoserin peptide molecule is:Propargyl-arginine-glutamic acid-aspartic acid-valine is more Peptide and the β-CD of 7 azido group modifications are:β-CD-(N3)7, click-reaction is carried out, arginine-glutamic acid-asparagus fern ammonia is made Peptide modified β-the CD of acid-valine.
7. method according to claim 1 or 2, it is characterised in that:The amidized base material is monocrystalline silicon or glass, institute The preparation process for stating amidized monocrystalline silicon piece or sheet glass is:Monocrystalline silicon piece or sheet glass are placed in the second of 3- aminopropyls-three TMOS(APTES)Toluene solution in react a period of time, obtain the monocrystalline silicon or glass baseplate of surface amination.
8. method according to claim 1 or 2, it is characterised in that:The amidized base material is gold-plated monocrystalline silicon piece, institute The preparation process for stating amidized gold-plated monocrystalline silicon piece is:Gold-plated monocrystalline silicon piece is placed in the aqueous solution of mercaptoethylamine hydrochloride Reaction a period of time, obtain the gold-plated single crystal silicon substrate of surface amination.
9. method according to claim 1 or 2, it is characterised in that:The β-cdderivatives of bioactive molecule are modified Solution be the aqueous solution, phosphate buffer solution or other can dissolve the solution of corresponding bioactive molecule.
10. method according to claim 2, it is characterised in that:Described is polymerized to Invertible ideal, The chain-transferring agent is 2-(Phenyl formyl sulfenyl)Propionic acid;Described initiator is azodiisobutyronitrile, azo two different heptan Nitrile, dibenzoyl peroxide, dicetyl peroxydicarbonate ethylhexyl, isopropyl benzene hydroperoxide, potassium peroxydisulfate-sulphite body System or hydrogen peroxide-perferrite system.
CN201610183773.7A 2016-03-29 2016-03-29 Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction Active CN105837730B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610183773.7A CN105837730B (en) 2016-03-29 2016-03-29 Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610183773.7A CN105837730B (en) 2016-03-29 2016-03-29 Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction

Publications (2)

Publication Number Publication Date
CN105837730A CN105837730A (en) 2016-08-10
CN105837730B true CN105837730B (en) 2017-10-10

Family

ID=56584809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610183773.7A Active CN105837730B (en) 2016-03-29 2016-03-29 Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction

Country Status (1)

Country Link
CN (1) CN105837730B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106634586B (en) * 2016-12-15 2020-02-18 东南大学 A kind of preparation method of host-guest self-healing transparent film
CN110479385A (en) * 2019-08-22 2019-11-22 浙江理工大学 A kind of hud typed Fe that cladding size is controllable3O4The preparation method of@hydrogel nanocatalyst
CN113388274B (en) * 2021-06-24 2022-03-08 中国科学院兰州化学物理研究所 Wear-resistant water-lubricating self-repairing coating and preparation method thereof
CN116410503A (en) * 2021-12-31 2023-07-11 江苏百赛飞生物科技有限公司 Multifunctional layer structure, preparation method and product thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101942105B (en) * 2010-09-03 2012-06-27 苏州大学 Polyurethane material capable of dissolving plasma clot in high efficiency and preparation thereof
CN104874031B (en) * 2015-04-20 2017-10-10 苏州大学 Polyurethane derivative for simulating human fibrinolytic system and vascular endothelial system, preparation method and preparation method of related product
CN104926976B (en) * 2015-04-27 2018-06-05 苏州大学 Glycosaminoglycan analogue, synthesis method thereof and application method thereof in-vitro embryonic stem cell proliferation and directional neural differentiation
CN104862288B (en) * 2015-05-08 2019-10-29 苏州大学 Synthesis of novel temperature-responsive inorganic pyrophosphatase conjugate and application of conjugate in enhanced polymerase chain reaction

Also Published As

Publication number Publication date
CN105837730A (en) 2016-08-10

Similar Documents

Publication Publication Date Title
Wang et al. Instant, tough, noncovalent adhesion
Xu et al. Covalent immobilization of glucose oxidase on well-defined poly (glycidyl methacrylate)− Si (111) hybrids from surface-initiated atom-transfer radical polymerization
CN105837730B (en) Method for constructing bioactive surface by combining layer-by-layer assembly technology and host-guest interaction
Ayres et al. Stimuli-responsive polyelectrolyte polymer brushes prepared via atom-transfer radical polymerization
Koev et al. Chitosan: an integrative biomaterial for lab-on-a-chip devices
Sato et al. Layer-by-layer thin films and microcapsules for biosensors and controlled release
CN108047860B (en) Preparation method of surface coating product with antifouling self-cleaning function
Qu et al. A reusable supramolecular platform for the specific capture and release of proteins and bacteria
CN105601976B (en) Method for preparing antibacterial surface on surface of biomedical material
CN104262668A (en) Polyurethane material with protein adsorption resistance and cell adhesion resistance and preparing method thereof
JP4630817B2 (en) Substance immobilizing agent, substance immobilizing method using the same, and substance immobilizing substrate using the same
Divandari et al. Controlling enzymatic polymerization from surfaces with switchable bioaffinity
CN105670022A (en) Preparation method of phosphorylcholine bionic coating
Xi-Feng et al. Surface modification of poly ethylene glycol to resist nonspecific adsorption of proteins
Song et al. Hemocompatibility enhancement of polyethersulfone membranes: Strategies and challenges
CN108129687B (en) A kind of surface is the preparation method of the imitating cell outer-layer membrane structure coating of Phosphorylcholine
CN107976472B (en) Preparation method of biological pollution-resistant coating on surface of sensor electrode
Saxena et al. Anti‐Fouling Polymer or Peptide‐Modified Electrochemical Biosensors for Improved Biosensing in Complex Media
CN106589366B (en) Pickering emulsion polymerization based on hydrophobic hydroxyapatite nano stable particle prepares method and the application of molecularly imprinted microspheres on surface
WO2017215683A1 (en) Method of preparation of a substrate containing carboxybetaine groups and bound bioactive substances which is resistant against undesirable deposition from biological media
Tong et al. Protein adsorption and cell adhesion on RGD-functionalized silicon substrate surfaces
Jung et al. Biofunctional structural design of SAW sensor chip surfaces in a microfluidic sensor system
Du et al. One-step preparation of vinyl-functionalized material surfaces: a versatile platform for surface modification
CN108047861B (en) Preparation method of surface coating product with dual responsiveness of temperature and pH
CN101810888A (en) Preparation method for material with high density fixed biologically functional molecule

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190513

Address after: 215024 8 Energy-saving (Suzhou) Environmental Science and Technology Industrial Park, No. 18 Dongchang Road, Suzhou Industrial Park, Jiangsu Province

Patentee after: Suzhou Hongfeng Hongfeng biological science and Technology Co., Ltd.

Address before: 215000 Ren'ai Road, Suzhou Industrial Park, Suzhou City, Jiangsu Province, 199

Patentee before: Soochow University

TR01 Transfer of patent right